Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 7500 | nM | 19757855 |
NPT393 | Cell Line | HCT-116 | Homo sapiens | IC50 | = | 8800 | nM | 19757855 |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | IC50 | > | 10000 | nM | 19757855 |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | > | 10000 | nM | 19757855 |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | > | 10000 | nM | 19757855 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 2.5 | mg/kg | 26900761 |
NPT1682 | Individual Protein | Dual specificity protein kinase CLK2 | Homo sapiens | Activity | = | 45 | % | 27363938 |
NPT3409 | Individual Protein | Homeodomain-interacting protein kinase 3 | Homo sapiens | Activity | = | 100 | % | 27363938 |
NPT3432 | Individual Protein | Homeodomain-interacting protein kinase 2 | Homo sapiens | Activity | = | 76 | % | 27363938 |
NPT3444 | Individual Protein | Homeodomain-interacting protein kinase 1 | Homo sapiens | Activity | = | 96 | % | 27363938 |
NPT4446 | Individual Protein | Eukaryotic translation initiation factor 2-alpha kinase 3 | Homo sapiens | Activity | = | 82 | % | 27363938 |
NPT1344 | Individual Protein | Serine/threonine-protein kinase EEF2K | Homo sapiens | Activity | = | 84 | % | 27363938 |
NPT3291 | Individual Protein | Serine/threonine-protein kinase SRPK1 | Homo sapiens | Activity | = | 40 | % | 27363938 |
NPT1701 | Individual Protein | Serine/threonine-protein kinase PIM3 | Homo sapiens | Activity | = | 12 | % | 27363938 |
NPT1700 | Individual Protein | Serine/threonine-protein kinase PIM2 | Homo sapiens | Activity | = | 67 | % | 27363938 |
NPT1265 | Individual Protein | Serine/threonine-protein kinase PIM1 | Homo sapiens | Activity | = | 27 | % | 27363938 |
NPT3417 | Individual Protein | Serine/threonine-protein kinase TBK1 | Homo sapiens | Activity | = | 55 | % | 27363938 |
NPT3275 | Individual Protein | Inhibitor of nuclear factor kappa B kinase epsilon subunit | Homo sapiens | Activity | = | 69 | % | 27363938 |
NPT981 | Individual Protein | Inhibitor of nuclear factor kappa B kinase beta subunit | Homo sapiens | Activity | = | 83 | % | 27363938 |
NPT1657 | Individual Protein | Serine/threonine-protein kinase NEK6 | Homo sapiens | Activity | = | 84 | % | 27363938 |
NPT1658 | Individual Protein | Serine/threonine-protein kinase NEK2 | Homo sapiens | Activity | = | 89 | % | 27363938 |
NPT3460 | Individual Protein | Dual-specificity tyrosine-phosphorylation regulated kinase 3 | Homo sapiens | Activity | = | 77 | % | 27363938 |
NPT3399 | Individual Protein | Dual-specificity tyrosine-phosphorylation regulated kinase 2 | Homo sapiens | Activity | = | 84 | % | 27363938 |
NPT3114 | Individual Protein | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | Homo sapiens | Activity | = | 27 | % | 27363938 |
NPT4447 | Individual Protein | Tau-tubulin kinase 1 | Homo sapiens | Activity | = | 82 | % | 27363938 |
NPT1609 | Protein Complex | Casein kinase II | Homo sapiens | Activity | = | 90 | % | 27363938 |
NPT3266 | Individual Protein | Casein kinase I delta | Homo sapiens | Activity | = | 78 | % | 27363938 |
NPT1685 | Individual Protein | Casein kinase I gamma 2 | Homo sapiens | Activity | = | 92 | % | 27363938 |
NPT3299 | Individual Protein | Testis-specific serine/threonine-protein kinase 1 | Homo sapiens | Activity | = | 81 | % | 27363938 |
NPT3378 | Individual Protein | Serine/threonine-protein kinase SIK3 | Homo sapiens | Activity | = | 28 | % | 27363938 |
NPT1432 | Individual Protein | Serine/threonine-protein kinase Aurora-A | Homo sapiens | Activity | = | 91 | % | 27363938 |
NPT3290 | Individual Protein | Serine/threonine-protein kinase SIK2 | Homo sapiens | Activity | = | 19 | % | 27363938 |
NPT1660 | Individual Protein | NUAK family SNF1-like kinase 1 | Homo sapiens | Activity | = | 52 | % | 27363938 |
NPT3282 | Individual Protein | Maternal embryonic leucine zipper kinase | Homo sapiens | Activity | = | 80 | % | 27363938 |
NPT3344 | Individual Protein | BR serine/threonine-protein kinase 2 | Homo sapiens | Activity | = | 65 | % | 27363938 |
NPT3315 | Individual Protein | BR serine/threonine-protein kinase 1 | Homo sapiens | Activity | = | 36 | % | 27363938 |
NPT3318 | Individual Protein | MAP/microtubule affinity-regulating kinase 4 | Homo sapiens | Activity | = | 92 | % | 27363938 |
NPT3280 | Individual Protein | Serine/threonine-protein kinase c-TAK1 | Homo sapiens | Activity | = | 41 | % | 27363938 |
NPT3235 | Individual Protein | MAP/microtubule affinity-regulating kinase 2 | Homo sapiens | Activity | = | 69 | % | 27363938 |
NPT3317 | Individual Protein | Serine/threonine-protein kinase MARK1 | Homo sapiens | Activity | = | 67 | % | 27363938 |
NPT1767 | Protein Complex | AMP-activated protein kinase, AMPK | Homo sapiens | Activity | = | 16 | % | 27363938 |
NPT3279 | Individual Protein | Serine/threonine-protein kinase 11 | Homo sapiens | Activity | = | 59 | % | 27363938 |
NPT3268 | Individual Protein | Serine/threonine-protein kinase tousled-like 1 | Homo sapiens | Activity | = | 109 | % | 27363938 |
NPT1433 | Individual Protein | Serine/threonine-protein kinase Aurora-B | Homo sapiens | Activity | = | 58 | % | 27363938 |
NPT831 | Individual Protein | Serine/threonine-protein kinase PLK1 | Homo sapiens | Activity | = | 96 | % | 27363938 |
NPT4092 | Protein Complex | CDK9/cyclin T1 | Homo sapiens | Activity | = | 7 | % | 27363938 |
NPT4158 | Protein Complex | CDK2/Cyclin A | Homo sapiens | Activity | = | 16 | % | 27363938 |
NPT591 | Individual Protein | Glycogen synthase kinase-3 beta | Homo sapiens | Activity | = | 66 | % | 27363938 |
NPT1680 | Individual Protein | Serine/threonine-protein kinase Chk2 | Homo sapiens | Activity | = | 60 | % | 27363938 |
NPT1608 | Individual Protein | Serine/threonine-protein kinase Chk1 | Homo sapiens | Activity | = | 52 | % | 27363938 |
NPT1721 | Individual Protein | Death-associated protein kinase 1 | Homo sapiens | Activity | = | 96 | % | 27363938 |
NPT4086 | Protein Complex | Phosphorylase kinase | Homo sapiens | Activity | = | 23 | % | 27363938 |
NPT2626 | Individual Protein | Myosin light chain kinase, smooth muscle | Homo sapiens | Activity | = | 78 | % | 27363938 |
NPT3232 | Individual Protein | CaM kinase I alpha | Homo sapiens | Activity | = | 76 | % | 27363938 |
NPT1678 | Individual Protein | CaM-kinase kinase beta | Homo sapiens | Activity | = | 18 | % | 27363938 |
NPT1612 | Individual Protein | MAP kinase-activated protein kinase 5 | Homo sapiens | Activity | = | 72 | % | 27363938 |
NPT3461 | Individual Protein | MAP kinase-activated protein kinase 3 | Homo sapiens | Activity | = | 83 | % | 27363938 |
NPT1441 | Individual Protein | MAP kinase-activated protein kinase 2 | Homo sapiens | Activity | = | 52 | % | 27363938 |
NPT3213 | Individual Protein | MAP kinase signal-integrating kinase 2 | Homo sapiens | Activity | = | 49 | % | 27363938 |
NPT3283 | Individual Protein | MAP kinase-interacting serine/threonine-protein kinase MNK1 | Homo sapiens | Activity | = | 88 | % | 27363938 |
NPT1613 | Individual Protein | Ribosomal protein S6 kinase alpha 5 | Homo sapiens | Activity | = | 30 | % | 27363938 |
NPT3296 | Individual Protein | Serine/threonine-protein kinase 33 | Homo sapiens | Activity | = | 54 | % | 27363938 |
NPT3364 | Individual Protein | Protein kinase C mu | Homo sapiens | Activity | = | 75 | % | 27363938 |
NPT3455 | Individual Protein | Protein kinase C zeta | Homo sapiens | Activity | = | 118 | % | 27363938 |
NPT880 | Individual Protein | Protein kinase C gamma | Homo sapiens | Activity | = | 89 | % | 27363938 |
NPT182 | Individual Protein | Protein kinase C alpha | Homo sapiens | Activity | = | 78 | % | 27363938 |
NPT3357 | Individual Protein | Protein kinase N2 | Homo sapiens | Activity | = | 42 | % | 27363938 |
NPT1610 | Individual Protein | Rho-associated protein kinase 2 | Rattus norvegicus | Activity | = | 64 | % | 27363938 |
NPT2 | Others | Unspecified | Activity | = | 88 | % | 27363938 | |
NPT1611 | Individual Protein | Ribosomal protein S6 kinase 1 | Homo sapiens | Activity | = | 79 | % | 27363938 |
NPT1448 | Individual Protein | Serine/threonine-protein kinase Sgk1 | Homo sapiens | Activity | = | 92 | % | 27363938 |
NPT1430 | Individual Protein | Serine/threonine-protein kinase AKT2 | Homo sapiens | Activity | = | 80 | % | 27363938 |
NPT728 | Individual Protein | Serine/threonine-protein kinase AKT | Homo sapiens | Activity | = | 76 | % | 27363938 |
NPT1699 | Individual Protein | 3-phosphoinositide dependent protein kinase-1 | Homo sapiens | Activity | = | 90 | % | 27363938 |
NPT3234 | Individual Protein | Ribosomal protein S6 kinase alpha 2 | Homo sapiens | Activity | = | 45 | % | 27363938 |
NPT3106 | Individual Protein | Ribosomal protein S6 kinase alpha 1 | Homo sapiens | Activity | = | 31 | % | 27363938 |
NPT3363 | Individual Protein | Mitogen-activated protein kinase 15 | Homo sapiens | Activity | = | 19 | % | 27363938 |
NPT1614 | Individual Protein | MAP kinase p38 delta | Homo sapiens | Activity | = | 16 | % | 27363938 |
NPT1615 | Individual Protein | MAP kinase p38 gamma | Homo sapiens | Activity | = | 27 | % | 27363938 |
NPT1616 | Individual Protein | MAP kinase p38 beta | Homo sapiens | Activity | = | 76 | % | 27363938 |
NPT283 | Individual Protein | MAP kinase p38 alpha | Homo sapiens | Activity | = | 69 | % | 27363938 |
NPT3207 | Individual Protein | c-Jun N-terminal kinase 3 | Homo sapiens | Activity | = | 87 | % | 27363938 |
NPT1427 | Individual Protein | c-Jun N-terminal kinase 2 | Homo sapiens | Activity | = | 107 | % | 27363938 |
NPT1426 | Individual Protein | c-Jun N-terminal kinase 1 | Homo sapiens | Activity | = | 96 | % | 27363938 |
NPT281 | Individual Protein | MAP kinase ERK1 | Homo sapiens | Activity | = | 86 | % | 27363938 |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | Activity | = | 90 | % | 27363938 |
NPT1691 | Individual Protein | Dual specificity mitogen-activated protein kinase kinase 6 | Homo sapiens | Activity | = | 89 | % | 27363938 |
NPT1690 | Individual Protein | Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens | Activity | = | 44 | % | 27363938 |
NPT491 | Individual Protein | Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens | Activity | = | 27 | % | 27363938 |
NPT4092 | Protein Complex | CDK9/cyclin T1 | Homo sapiens | Inhibition | = | 75 | % | 27363938 |
NPT4158 | Protein Complex | CDK2/Cyclin A | Homo sapiens | Inhibition | = | 10 | % | 27363938 |
NPT71 | Cell Line | HEK293 | Homo sapiens | GI50 | > | 50000 | nM | 27363938 |
NPT2 | Others | Unspecified | GI50 | > | 50000 | nM | 27363938 | |
NPT2 | Others | Unspecified | GI50 | = | 30000 | nM | 27363938 | |
NPT2 | Others | Unspecified | GI50 | = | 22000 | nM | 27363938 | |
NPT75 | Cell Line | U251 | Homo sapiens | GI50 | = | 32000 | nM | 27363938 |
NPT2 | Others | Unspecified | GI50 | = | 27000 | nM | 27363938 | |
NPT2 | Others | Unspecified | GI50 | = | 20000 | nM | 27363938 | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | = | 24000 | nM | 27363938 |
NPT784 | Cell Line | MDA-MB-468 | Homo sapiens | GI50 | = | 17000 | nM | 27363938 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | = | 13000 | nM | 27363938 |
NPT858 | Cell Line | LNCaP | Homo sapiens | GI50 | = | 30000 | nM | 27363938 |
NPT2 | Others | Unspecified | GI50 | = | 26000 | nM | 27363938 | |
NPT2 | Others | Unspecified | GI50 | = | 19000 | nM | 27363938 | |
NPT2107 | Cell Line | PSN1 | Homo sapiens | GI50 | = | 23000 | nM | 27363938 |
NPT2297 | Cell Line | ASPC1 | Homo sapiens | GI50 | = | 21000 | nM | 27363938 |
NPT2 | Others | Unspecified | GI50 | = | 28000 | nM | 27363938 | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | = | 24000 | nM | 27363938 |
NPT2 | Others | Unspecified | GI50 | = | 12000 | nM | 27363938 | |
NPT2 | Others | Unspecified | GI50 | = | 10000 | nM | 27363938 | |
NPT1442 | Individual Protein | Serine/threonine-protein kinase PAK 2 | Homo sapiens | Activity | = | 88 | % | 27363938 |
NPT1695 | Individual Protein | Serine/threonine-protein kinase PAK 4 | Homo sapiens | Activity | = | 83 | % | 27363938 |
NPT1696 | Individual Protein | Serine/threonine-protein kinase PAK7 | Homo sapiens | Activity | = | 87 | % | 27363938 |
NPT1697 | Individual Protein | Serine/threonine-protein kinase PAK6 | Homo sapiens | Activity | = | 79 | % | 27363938 |
NPT3331 | Individual Protein | Serine/threonine-protein kinase MST2 | Homo sapiens | Activity | = | 46 | % | 27363938 |
NPT3332 | Individual Protein | Serine/threonine-protein kinase 24 | Homo sapiens | Activity | = | 85 | % | 27363938 |
NPT1693 | Individual Protein | Serine/threonine-protein kinase MST4 | Homo sapiens | Activity | = | 68 | % | 27363938 |
NPT4448 | Individual Protein | Hexokinase type IV | Homo sapiens | Activity | = | 17 | % | 27363938 |
NPT3381 | Individual Protein | Misshapen-like kinase 1 | Homo sapiens | Activity | = | 73 | % | 27363938 |
NPT3411 | Individual Protein | Mitogen-activated protein kinase kinase kinase 1 | Homo sapiens | Activity | = | 83 | % | 27363938 |
NPT3411 | Individual Protein | Mitogen-activated protein kinase kinase kinase 1 | Homo sapiens | Activity | = | 47 | % | 27363938 |
NPT3328 | Individual Protein | Mitogen-activated protein kinase kinase kinase 11 | Homo sapiens | Activity | = | 58 | % | 27363938 |
NPT3352 | Individual Protein | Dual specificity testis-specific protein kinase 1 | Homo sapiens | Activity | = | 88 | % | 27363938 |
NPT3431 | Individual Protein | Serine/threonine-protein kinase TAO1 | Homo sapiens | Activity | = | 39 | % | 27363938 |
NPT1431 | Individual Protein | Mitogen-activated protein kinase kinase kinase 5 | Homo sapiens | Activity | = | 96 | % | 27363938 |
NPT3442 | Individual Protein | Mitogen-activated protein kinase kinase kinase 7 | Homo sapiens | Activity | = | 70 | % | 27363938 |
NPT3386 | Individual Protein | Interleukin-1 receptor-associated kinase 1 | Homo sapiens | Activity | = | 55 | % | 27363938 |
NPT3425 | Individual Protein | Interleukin-1 receptor-associated kinase 4 | Homo sapiens | Activity | = | 75 | % | 27363938 |
NPT1447 | Individual Protein | Serine/threonine-protein kinase RIPK2 | Homo sapiens | Activity | = | 63 | % | 27363938 |
NPT1694 | Individual Protein | Serine/threonine-protein kinase OSR1 | Homo sapiens | Activity | = | 93 | % | 27363938 |
NPT3238 | Individual Protein | Dual specificity protein kinase TTK | Homo sapiens | Activity | = | 56 | % | 27363938 |
NPT1708 | Individual Protein | Serine/threonine-protein kinase 16 | Homo sapiens | Activity | = | 87 | % | 27363938 |
NPT4449 | Individual Protein | Serine/threonine-protein kinase WNK1 | Homo sapiens | Activity | = | 100 | % | 27363938 |
NPT36 | Individual Protein | Tyrosine-protein kinase SRC | Homo sapiens | Activity | = | 61 | % | 27363938 |
NPT13 | Individual Protein | Tyrosine-protein kinase LCK | Homo sapiens | Activity | = | 45 | % | 27363938 |
NPT3113 | Individual Protein | Tyrosine-protein kinase CSK | Homo sapiens | Activity | = | 79 | % | 27363938 |
NPT1663 | Individual Protein | Tyrosine-protein kinase YES | Homo sapiens | Activity | = | 57 | % | 27363938 |
NPT2729 | Individual Protein | Tyrosine-protein kinase ABL | Homo sapiens | Activity | = | 87 | % | 27363938 |
NPT833 | Individual Protein | Tyrosine-protein kinase BTK | Homo sapiens | Activity | = | 58 | % | 27363938 |
NPT3246 | Individual Protein | Tyrosine-protein kinase JAK2 | Homo sapiens | Activity | = | 41 | % | 27363938 |
NPT1449 | Individual Protein | Tyrosine-protein kinase SYK | Homo sapiens | Activity | = | 109 | % | 27363938 |
NPT3259 | Individual Protein | Tyrosine-protein kinase ZAP-70 | Homo sapiens | Activity | = | 103 | % | 27363938 |
NPT2576 | Individual Protein | Tyrosine-protein kinase TIE-2 | Homo sapiens | Activity | = | 80 | % | 27363938 |
NPT3215 | Individual Protein | Tyrosine-protein kinase BRK | Homo sapiens | Activity | = | 93 | % | 27363938 |
NPT3225 | Individual Protein | Ephrin type-A receptor 2 | Homo sapiens | Activity | = | 38 | % | 27363938 |
NPT3218 | Individual Protein | Ephrin type-A receptor 4 | Homo sapiens | Activity | = | 53 | % | 27363938 |
NPT3212 | Individual Protein | Ephrin type-B receptor 1 | Homo sapiens | Activity | = | 54 | % | 27363938 |
NPT2941 | Individual Protein | Ephrin type-B receptor 2 | Homo sapiens | Activity | = | 81 | % | 27363938 |
NPT3359 | Individual Protein | Ephrin type-B receptor 3 | Homo sapiens | Activity | = | 82 | % | 27363938 |
NPT2572 | Individual Protein | Ephrin type-B receptor 4 | Homo sapiens | Activity | = | 84 | % | 27363938 |
NPT1480 | Individual Protein | Fibroblast growth factor receptor 1 | Homo sapiens | Activity | = | 66 | % | 27363938 |
NPT1435 | Individual Protein | Receptor protein-tyrosine kinase erbB-4 | Homo sapiens | Activity | = | 79 | % | 27363938 |
NPT1438 | Individual Protein | Insulin-like growth factor I receptor | Homo sapiens | Activity | = | 113 | % | 27363938 |
NPT2574 | Individual Protein | Insulin receptor | Homo sapiens | Activity | = | 91 | % | 27363938 |
NPT3286 | Individual Protein | Insulin receptor-related protein | Homo sapiens | Activity | = | 53 | % | 27363938 |
NPT3239 | Individual Protein | Nerve growth factor receptor Trk-A | Homo sapiens | Activity | = | 89 | % | 27363938 |
NPT3303 | Individual Protein | Discoidin domain-containing receptor 2 | Homo sapiens | Activity | = | 79 | % | 27363938 |
NPT4450 | Protein Family | Vascular endothelial growth factor receptor | Homo sapiens | Activity | = | 18 | % | 27363938 |
NPT2 | Others | Unspecified | Activity | = | 1 | % | 27363938 | |
NPT2 | Others | Unspecified | Activity | = | 4 | % | 27363938 | |
NPT2 | Others | Unspecified | Activity | = | 10 | % | 27363938 | |
NPT2 | Others | Unspecified | Activity | = | 34 | % | 27363938 | |
NPT2 | Others | Unspecified | Activity | = | 56 | % | 27363938 | |
NPT2 | Others | Unspecified | Activity | = | 48 | % | 27363938 | |
NPT2 | Others | Unspecified | Activity | = | 13 | % | 27363938 | |
NPT2 | Others | Unspecified | Activity | = | 11 | % | 27363938 | |
NPT2 | Others | Unspecified | Activity | = | 50 | % | 27363938 | |
NPT2 | Others | Unspecified | Activity | = | 43 | % | 27363938 | |
NPT4158 | Protein Complex | CDK2/Cyclin A | Homo sapiens | IC50 | = | 7300 | nM | 27363938 |
NPT4092 | Protein Complex | CDK9/cyclin T1 | Homo sapiens | IC50 | = | 300 | nM | 27363938 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC129578 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.963 | High Similarity | NPC309692 |
0.9231 | High Similarity | NPC469437 |
0.9128 | High Similarity | NPC264938 |
0.8914 | High Similarity | NPC204580 |
0.8864 | High Similarity | NPC83019 |
0.8571 | High Similarity | NPC139966 |
0.8571 | High Similarity | NPC307052 |
0.8553 | High Similarity | NPC224714 |
0.8553 | High Similarity | NPC470890 |
0.8509 | High Similarity | NPC10097 |
0.85 | High Similarity | NPC472629 |
0.8488 | Intermediate Similarity | NPC327005 |
0.8471 | Intermediate Similarity | NPC139554 |
0.8447 | Intermediate Similarity | NPC308200 |
0.8447 | Intermediate Similarity | NPC470670 |
0.8447 | Intermediate Similarity | NPC47388 |
0.8447 | Intermediate Similarity | NPC473133 |
0.8447 | Intermediate Similarity | NPC85773 |
0.8438 | Intermediate Similarity | NPC271288 |
0.8438 | Intermediate Similarity | NPC124780 |
0.8438 | Intermediate Similarity | NPC87486 |
0.8405 | Intermediate Similarity | NPC471115 |
0.8405 | Intermediate Similarity | NPC29777 |
0.8395 | Intermediate Similarity | NPC145467 |
0.8395 | Intermediate Similarity | NPC470460 |
0.8395 | Intermediate Similarity | NPC39195 |
0.8385 | Intermediate Similarity | NPC290133 |
0.8385 | Intermediate Similarity | NPC187282 |
0.8385 | Intermediate Similarity | NPC474302 |
0.8385 | Intermediate Similarity | NPC24136 |
0.8375 | Intermediate Similarity | NPC77794 |
0.8375 | Intermediate Similarity | NPC278249 |
0.8375 | Intermediate Similarity | NPC107177 |
0.8375 | Intermediate Similarity | NPC223812 |
0.8375 | Intermediate Similarity | NPC81697 |
0.8375 | Intermediate Similarity | NPC125894 |
0.8375 | Intermediate Similarity | NPC85162 |
0.8365 | Intermediate Similarity | NPC279650 |
0.8365 | Intermediate Similarity | NPC166689 |
0.8365 | Intermediate Similarity | NPC258630 |
0.8365 | Intermediate Similarity | NPC17170 |
0.8365 | Intermediate Similarity | NPC156190 |
0.8365 | Intermediate Similarity | NPC96408 |
0.8354 | Intermediate Similarity | NPC470675 |
0.8354 | Intermediate Similarity | NPC473131 |
0.8344 | Intermediate Similarity | NPC471114 |
0.8344 | Intermediate Similarity | NPC473016 |
0.8344 | Intermediate Similarity | NPC5173 |
0.8344 | Intermediate Similarity | NPC470461 |
0.8333 | Intermediate Similarity | NPC296998 |
0.8333 | Intermediate Similarity | NPC300988 |
0.8333 | Intermediate Similarity | NPC10990 |
0.8333 | Intermediate Similarity | NPC91902 |
0.8333 | Intermediate Similarity | NPC473077 |
0.8323 | Intermediate Similarity | NPC131579 |
0.8323 | Intermediate Similarity | NPC473013 |
0.8323 | Intermediate Similarity | NPC473015 |
0.8323 | Intermediate Similarity | NPC235217 |
0.8323 | Intermediate Similarity | NPC311144 |
0.8323 | Intermediate Similarity | NPC131568 |
0.8323 | Intermediate Similarity | NPC473014 |
0.8313 | Intermediate Similarity | NPC227579 |
0.8313 | Intermediate Similarity | NPC182852 |
0.8313 | Intermediate Similarity | NPC223500 |
0.8313 | Intermediate Similarity | NPC228504 |
0.8313 | Intermediate Similarity | NPC107572 |
0.8313 | Intermediate Similarity | NPC76372 |
0.8313 | Intermediate Similarity | NPC64915 |
0.8313 | Intermediate Similarity | NPC66515 |
0.8313 | Intermediate Similarity | NPC40833 |
0.8313 | Intermediate Similarity | NPC167624 |
0.8313 | Intermediate Similarity | NPC148757 |
0.8313 | Intermediate Similarity | NPC161506 |
0.8313 | Intermediate Similarity | NPC194432 |
0.8313 | Intermediate Similarity | NPC166934 |
0.8313 | Intermediate Similarity | NPC328164 |
0.8313 | Intermediate Similarity | NPC324134 |
0.8313 | Intermediate Similarity | NPC1089 |
0.8313 | Intermediate Similarity | NPC78 |
0.8313 | Intermediate Similarity | NPC166482 |
0.8313 | Intermediate Similarity | NPC177354 |
0.8313 | Intermediate Similarity | NPC265040 |
0.8313 | Intermediate Similarity | NPC10937 |
0.8313 | Intermediate Similarity | NPC220998 |
0.8313 | Intermediate Similarity | NPC125855 |
0.8313 | Intermediate Similarity | NPC37496 |
0.8313 | Intermediate Similarity | NPC324436 |
0.8313 | Intermediate Similarity | NPC296917 |
0.8313 | Intermediate Similarity | NPC32739 |
0.8313 | Intermediate Similarity | NPC306829 |
0.8313 | Intermediate Similarity | NPC76338 |
0.8303 | Intermediate Similarity | NPC216035 |
0.8303 | Intermediate Similarity | NPC244583 |
0.8303 | Intermediate Similarity | NPC256141 |
0.8303 | Intermediate Similarity | NPC217149 |
0.8303 | Intermediate Similarity | NPC10807 |
0.8303 | Intermediate Similarity | NPC56232 |
0.8303 | Intermediate Similarity | NPC150123 |
0.8303 | Intermediate Similarity | NPC161881 |
0.8302 | Intermediate Similarity | NPC477272 |
0.8293 | Intermediate Similarity | NPC472633 |
0.8293 | Intermediate Similarity | NPC321896 |
0.8293 | Intermediate Similarity | NPC37348 |
0.8293 | Intermediate Similarity | NPC180351 |
0.8293 | Intermediate Similarity | NPC474735 |
0.8293 | Intermediate Similarity | NPC476185 |
0.8293 | Intermediate Similarity | NPC61258 |
0.8291 | Intermediate Similarity | NPC131130 |
0.8291 | Intermediate Similarity | NPC470671 |
0.8291 | Intermediate Similarity | NPC470672 |
0.8291 | Intermediate Similarity | NPC474504 |
0.8291 | Intermediate Similarity | NPC474487 |
0.8282 | Intermediate Similarity | NPC168085 |
0.828 | Intermediate Similarity | NPC156910 |
0.828 | Intermediate Similarity | NPC174999 |
0.828 | Intermediate Similarity | NPC470397 |
0.8272 | Intermediate Similarity | NPC195621 |
0.8272 | Intermediate Similarity | NPC474161 |
0.8272 | Intermediate Similarity | NPC477955 |
0.8272 | Intermediate Similarity | NPC476088 |
0.8272 | Intermediate Similarity | NPC20488 |
0.8272 | Intermediate Similarity | NPC301276 |
0.8272 | Intermediate Similarity | NPC83357 |
0.8272 | Intermediate Similarity | NPC127059 |
0.8272 | Intermediate Similarity | NPC267375 |
0.8272 | Intermediate Similarity | NPC142405 |
0.8272 | Intermediate Similarity | NPC285630 |
0.8272 | Intermediate Similarity | NPC299011 |
0.8272 | Intermediate Similarity | NPC54577 |
0.8272 | Intermediate Similarity | NPC67805 |
0.8272 | Intermediate Similarity | NPC470647 |
0.8272 | Intermediate Similarity | NPC111786 |
0.8272 | Intermediate Similarity | NPC176229 |
0.8272 | Intermediate Similarity | NPC470458 |
0.8272 | Intermediate Similarity | NPC214774 |
0.8272 | Intermediate Similarity | NPC475052 |
0.8272 | Intermediate Similarity | NPC246948 |
0.8272 | Intermediate Similarity | NPC312973 |
0.8272 | Intermediate Similarity | NPC88964 |
0.8261 | Intermediate Similarity | NPC475705 |
0.8261 | Intermediate Similarity | NPC143896 |
0.8261 | Intermediate Similarity | NPC470909 |
0.8261 | Intermediate Similarity | NPC51887 |
0.8261 | Intermediate Similarity | NPC150408 |
0.8261 | Intermediate Similarity | NPC39329 |
0.8261 | Intermediate Similarity | NPC316816 |
0.8261 | Intermediate Similarity | NPC476178 |
0.8261 | Intermediate Similarity | NPC169591 |
0.8261 | Intermediate Similarity | NPC164980 |
0.8261 | Intermediate Similarity | NPC113770 |
0.8261 | Intermediate Similarity | NPC221432 |
0.8261 | Intermediate Similarity | NPC75049 |
0.8261 | Intermediate Similarity | NPC257097 |
0.8261 | Intermediate Similarity | NPC175504 |
0.8261 | Intermediate Similarity | NPC214166 |
0.8261 | Intermediate Similarity | NPC68104 |
0.8261 | Intermediate Similarity | NPC18886 |
0.8261 | Intermediate Similarity | NPC149026 |
0.8261 | Intermediate Similarity | NPC474939 |
0.8261 | Intermediate Similarity | NPC310130 |
0.8261 | Intermediate Similarity | NPC185276 |
0.8261 | Intermediate Similarity | NPC117836 |
0.8261 | Intermediate Similarity | NPC91560 |
0.8261 | Intermediate Similarity | NPC478086 |
0.8261 | Intermediate Similarity | NPC96216 |
0.8253 | Intermediate Similarity | NPC223701 |
0.8253 | Intermediate Similarity | NPC7989 |
0.8253 | Intermediate Similarity | NPC469405 |
0.8253 | Intermediate Similarity | NPC472583 |
0.825 | Intermediate Similarity | NPC248372 |
0.825 | Intermediate Similarity | NPC282300 |
0.825 | Intermediate Similarity | NPC213322 |
0.825 | Intermediate Similarity | NPC324386 |
0.825 | Intermediate Similarity | NPC4743 |
0.825 | Intermediate Similarity | NPC312391 |
0.825 | Intermediate Similarity | NPC110038 |
0.8242 | Intermediate Similarity | NPC474023 |
0.8242 | Intermediate Similarity | NPC477897 |
0.8242 | Intermediate Similarity | NPC289774 |
0.8242 | Intermediate Similarity | NPC262039 |
0.8242 | Intermediate Similarity | NPC472422 |
0.8242 | Intermediate Similarity | NPC471677 |
0.8242 | Intermediate Similarity | NPC244577 |
0.8242 | Intermediate Similarity | NPC209846 |
0.8242 | Intermediate Similarity | NPC328740 |
0.8242 | Intermediate Similarity | NPC474021 |
0.8242 | Intermediate Similarity | NPC263384 |
0.8242 | Intermediate Similarity | NPC262038 |
0.8242 | Intermediate Similarity | NPC472420 |
0.8242 | Intermediate Similarity | NPC178484 |
0.8242 | Intermediate Similarity | NPC254412 |
0.8242 | Intermediate Similarity | NPC278476 |
0.8242 | Intermediate Similarity | NPC319910 |
0.8242 | Intermediate Similarity | NPC471676 |
0.8239 | Intermediate Similarity | NPC23257 |
0.8239 | Intermediate Similarity | NPC140890 |
0.8232 | Intermediate Similarity | NPC317492 |
0.8221 | Intermediate Similarity | NPC472627 |
0.8221 | Intermediate Similarity | NPC202494 |
0.8221 | Intermediate Similarity | NPC474108 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC129578 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9217 | High Similarity | NPD4419 | Clinical (unspecified phase) |
0.9128 | High Similarity | NPD4360 | Phase 2 |
0.9128 | High Similarity | NPD4363 | Phase 3 |
0.8644 | High Similarity | NPD4362 | Clinical (unspecified phase) |
0.8644 | High Similarity | NPD4361 | Phase 2 |
0.8235 | Intermediate Similarity | NPD5710 | Approved |
0.8235 | Intermediate Similarity | NPD5711 | Approved |
0.821 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.8152 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.8095 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.8072 | Intermediate Similarity | NPD4380 | Phase 2 |
0.8036 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.8012 | Intermediate Similarity | NPD2654 | Approved |
0.8 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.795 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7917 | Intermediate Similarity | NPD5890 | Approved |
0.7917 | Intermediate Similarity | NPD5889 | Approved |
0.7886 | Intermediate Similarity | NPD3446 | Phase 1 |
0.787 | Intermediate Similarity | NPD6844 | Discontinued |
0.7826 | Intermediate Similarity | NPD2796 | Approved |
0.7818 | Intermediate Similarity | NPD7213 | Phase 3 |
0.7818 | Intermediate Similarity | NPD7212 | Phase 2 |
0.7791 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7791 | Intermediate Similarity | NPD7075 | Discontinued |
0.7771 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7771 | Intermediate Similarity | NPD7447 | Phase 1 |
0.7765 | Intermediate Similarity | NPD1934 | Approved |
0.7764 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7759 | Intermediate Similarity | NPD6959 | Discontinued |
0.7751 | Intermediate Similarity | NPD6585 | Discontinued |
0.7719 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7719 | Intermediate Similarity | NPD7819 | Suspended |
0.7708 | Intermediate Similarity | NPD7584 | Approved |
0.7706 | Intermediate Similarity | NPD7411 | Suspended |
0.7697 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7683 | Intermediate Similarity | NPD2800 | Approved |
0.7661 | Intermediate Similarity | NPD6801 | Discontinued |
0.7661 | Intermediate Similarity | NPD7577 | Discontinued |
0.7625 | Intermediate Similarity | NPD3142 | Approved |
0.7625 | Intermediate Similarity | NPD3140 | Approved |
0.7622 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7572 | Intermediate Similarity | NPD5353 | Approved |
0.7545 | Intermediate Similarity | NPD6667 | Approved |
0.7545 | Intermediate Similarity | NPD6666 | Approved |
0.7542 | Intermediate Similarity | NPD7893 | Clinical (unspecified phase) |
0.7528 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7528 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7528 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7528 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7516 | Intermediate Similarity | NPD1240 | Approved |
0.7514 | Intermediate Similarity | NPD2801 | Approved |
0.75 | Intermediate Similarity | NPD1511 | Approved |
0.75 | Intermediate Similarity | NPD5494 | Approved |
0.7487 | Intermediate Similarity | NPD7701 | Phase 2 |
0.7485 | Intermediate Similarity | NPD2200 | Suspended |
0.7463 | Intermediate Similarity | NPD4111 | Phase 1 |
0.7463 | Intermediate Similarity | NPD4665 | Approved |
0.7456 | Intermediate Similarity | NPD2534 | Approved |
0.7456 | Intermediate Similarity | NPD2533 | Approved |
0.7456 | Intermediate Similarity | NPD2532 | Approved |
0.7429 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7423 | Intermediate Similarity | NPD6651 | Approved |
0.7423 | Intermediate Similarity | NPD1607 | Approved |
0.7412 | Intermediate Similarity | NPD1512 | Approved |
0.7403 | Intermediate Similarity | NPD7054 | Approved |
0.7403 | Intermediate Similarity | NPD6020 | Phase 2 |
0.7399 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7398 | Intermediate Similarity | NPD7585 | Approved |
0.7384 | Intermediate Similarity | NPD8158 | Clinical (unspecified phase) |
0.7381 | Intermediate Similarity | NPD3295 | Clinical (unspecified phase) |
0.7368 | Intermediate Similarity | NPD7427 | Discontinued |
0.7363 | Intermediate Similarity | NPD7472 | Approved |
0.7363 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7358 | Intermediate Similarity | NPD2494 | Approved |
0.7358 | Intermediate Similarity | NPD2493 | Approved |
0.7353 | Intermediate Similarity | NPD4661 | Approved |
0.7353 | Intermediate Similarity | NPD4662 | Approved |
0.7348 | Intermediate Similarity | NPD7177 | Discontinued |
0.7348 | Intermediate Similarity | NPD5940 | Clinical (unspecified phase) |
0.7348 | Intermediate Similarity | NPD3818 | Discontinued |
0.7347 | Intermediate Similarity | NPD7583 | Approved |
0.7344 | Intermediate Similarity | NPD7811 | Phase 3 |
0.7344 | Intermediate Similarity | NPD7810 | Phase 3 |
0.7333 | Intermediate Similarity | NPD4575 | Clinical (unspecified phase) |
0.7333 | Intermediate Similarity | NPD4582 | Approved |
0.7333 | Intermediate Similarity | NPD4583 | Approved |
0.733 | Intermediate Similarity | NPD2975 | Approved |
0.733 | Intermediate Similarity | NPD2974 | Approved |
0.733 | Intermediate Similarity | NPD5019 | Clinical (unspecified phase) |
0.733 | Intermediate Similarity | NPD2973 | Approved |
0.7322 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7321 | Intermediate Similarity | NPD3750 | Approved |
0.732 | Intermediate Similarity | NPD5006 | Approved |
0.732 | Intermediate Similarity | NPD5005 | Approved |
0.7306 | Intermediate Similarity | NPD4580 | Approved |
0.7304 | Intermediate Similarity | NPD7907 | Approved |
0.7295 | Intermediate Similarity | NPD8469 | Approved |
0.7294 | Intermediate Similarity | NPD7837 | Clinical (unspecified phase) |
0.7294 | Intermediate Similarity | NPD6799 | Approved |
0.7283 | Intermediate Similarity | NPD6559 | Discontinued |
0.7283 | Intermediate Similarity | NPD7251 | Discontinued |
0.7282 | Intermediate Similarity | NPD4004 | Approved |
0.7282 | Intermediate Similarity | NPD4002 | Approved |
0.7273 | Intermediate Similarity | NPD3863 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7268 | Intermediate Similarity | NPD3452 | Approved |
0.7268 | Intermediate Similarity | NPD3450 | Approved |
0.7267 | Intermediate Similarity | NPD920 | Approved |
0.7262 | Intermediate Similarity | NPD1243 | Approved |
0.7262 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7257 | Intermediate Similarity | NPD6280 | Approved |
0.7257 | Intermediate Similarity | NPD6279 | Approved |
0.7254 | Intermediate Similarity | NPD8285 | Discontinued |
0.7243 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7243 | Intermediate Similarity | NPD7549 | Discontinued |
0.7241 | Intermediate Similarity | NPD6599 | Discontinued |
0.7238 | Intermediate Similarity | NPD3451 | Clinical (unspecified phase) |
0.7232 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7232 | Intermediate Similarity | NPD3882 | Suspended |
0.7231 | Intermediate Similarity | NPD3057 | Approved |
0.7228 | Intermediate Similarity | NPD3823 | Discontinued |
0.7222 | Intermediate Similarity | NPD6808 | Phase 2 |
0.7219 | Intermediate Similarity | NPD7466 | Approved |
0.7219 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7216 | Intermediate Similarity | NPD6668 | Clinical (unspecified phase) |
0.7213 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7202 | Intermediate Similarity | NPD4420 | Approved |
0.7198 | Intermediate Similarity | NPD7473 | Discontinued |
0.7195 | Intermediate Similarity | NPD2238 | Phase 2 |
0.7191 | Intermediate Similarity | NPD3749 | Approved |
0.7189 | Intermediate Similarity | NPD7039 | Approved |
0.7189 | Intermediate Similarity | NPD6104 | Discontinued |
0.7189 | Intermediate Similarity | NPD7038 | Approved |
0.7186 | Intermediate Similarity | NPD6099 | Approved |
0.7186 | Intermediate Similarity | NPD4476 | Approved |
0.7186 | Intermediate Similarity | NPD4477 | Approved |
0.7186 | Intermediate Similarity | NPD6100 | Approved |
0.7182 | Intermediate Similarity | NPD5242 | Approved |
0.7178 | Intermediate Similarity | NPD7930 | Approved |
0.7178 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7168 | Intermediate Similarity | NPD5403 | Approved |
0.7158 | Intermediate Similarity | NPD2488 | Approved |
0.7158 | Intermediate Similarity | NPD2490 | Approved |
0.7157 | Intermediate Similarity | NPD8320 | Phase 1 |
0.7157 | Intermediate Similarity | NPD8319 | Approved |
0.7152 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7152 | Intermediate Similarity | NPD4622 | Approved |
0.7152 | Intermediate Similarity | NPD4618 | Approved |
0.7151 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7151 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD2972 | Approved |
0.7143 | Intermediate Similarity | NPD2491 | Approved |
0.7143 | Intermediate Similarity | NPD3533 | Approved |
0.7136 | Intermediate Similarity | NPD8366 | Approved |
0.7135 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7128 | Intermediate Similarity | NPD6778 | Approved |
0.7128 | Intermediate Similarity | NPD6780 | Approved |
0.7128 | Intermediate Similarity | NPD6776 | Approved |
0.7128 | Intermediate Similarity | NPD6779 | Approved |
0.7128 | Intermediate Similarity | NPD6782 | Approved |
0.7128 | Intermediate Similarity | NPD6781 | Approved |
0.7128 | Intermediate Similarity | NPD6777 | Approved |
0.7127 | Intermediate Similarity | NPD6232 | Discontinued |
0.7126 | Intermediate Similarity | NPD2799 | Discontinued |
0.7118 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7114 | Intermediate Similarity | NPD7783 | Phase 2 |
0.7114 | Intermediate Similarity | NPD7782 | Clinical (unspecified phase) |
0.7114 | Intermediate Similarity | NPD5676 | Approved |
0.71 | Intermediate Similarity | NPD8151 | Discontinued |
0.7095 | Intermediate Similarity | NPD8005 | Clinical (unspecified phase) |
0.7085 | Intermediate Similarity | NPD6973 | Clinical (unspecified phase) |
0.7083 | Intermediate Similarity | NPD2935 | Discontinued |
0.7083 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7081 | Intermediate Similarity | NPD1729 | Discontinued |
0.7081 | Intermediate Similarity | NPD8491 | Approved |
0.7079 | Intermediate Similarity | NPD5402 | Approved |
0.7079 | Intermediate Similarity | NPD5616 | Clinical (unspecified phase) |
0.7073 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7068 | Intermediate Similarity | NPD3808 | Clinical (unspecified phase) |
0.7066 | Intermediate Similarity | NPD5688 | Approved |
0.7066 | Intermediate Similarity | NPD5689 | Approved |
0.7059 | Intermediate Similarity | NPD2976 | Clinical (unspecified phase) |
0.7056 | Intermediate Similarity | NPD3448 | Approved |
0.7055 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7052 | Intermediate Similarity | NPD5401 | Approved |
0.7049 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7043 | Intermediate Similarity | NPD5953 | Discontinued |
0.7041 | Intermediate Similarity | NPD7030 | Discontinued |
0.7037 | Intermediate Similarity | NPD6990 | Approved |
0.7037 | Intermediate Similarity | NPD6989 | Approved |
0.7027 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7027 | Intermediate Similarity | NPD3050 | Clinical (unspecified phase) |
0.7027 | Intermediate Similarity | NPD42 | Phase 2 |
0.7027 | Intermediate Similarity | NPD6042 | Phase 2 |
0.7024 | Intermediate Similarity | NPD3748 | Approved |
0.7022 | Intermediate Similarity | NPD7046 | Clinical (unspecified phase) |
0.7021 | Intermediate Similarity | NPD2971 | Approved |
0.7021 | Intermediate Similarity | NPD2968 | Approved |
PubChem CID   | 13422573 |
ChEMBL   | CHEMBL1077604 |
ZINC   |
Molecular Weight:   | 305.13 |
ALogP:   | -1.9508 |
MLogP:   | 2.56 |
XLogP:   | -0.333 |
# Rotatable Bonds:   | 6 |
Polar Surface Area:   | 90.23 |
# H-Bond Aceptor:   | 3 |
# H-Bond Donor:   | 3 |
# Rings:   | 3 |
# Heavy Atoms:   | 22 |